TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2013

Randomized phase II study of the anti-epidermal growth factor receptor monoclonal antibody cetuximab with cisplatin versus cisplatin alone in patients with metastatic triple-negative breast cancer.

José Baselga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.